Cardio-oncology最新文献_第3页

Temporal trends in cardiac arrest and cancer-related mortality among adults in the United States, 1999-2023. 1999-2023年美国成年人心脏骤停和癌症相关死亡率的时间趋势

IF 3.2

Cardio-oncology Pub Date : 2026-04-13 DOI: 10.1186/s40959-026-00483-1

Reja Ahmad, Muhammad Salik Uddin, Urooj Amjad, Hasibullah Aminpoor, Muhammad Ahsan, Aafia Imran, Muhammad Zubair Farooq, Abdur Rafay Bilal, Asim Sajjad, Muhammad Ahmed, Muhammad Mubariz, Saad Ahmed Waqas

引用次数: 0

Cardiotoxicity prevention trials in the era of contemporary cancer therapies: a systematic review. 当代癌症治疗时代的心脏毒性预防试验：系统综述。

IF 3.2

Cardio-oncology Pub Date : 2026-04-11 DOI: 10.1186/s40959-026-00464-4

Malak Munir, Ahmed Sayed, Sanam Ghazi, Eric H Yang, Avirup Guha, Narendranath Epperla, Daniel Addison

引用次数: 0

Finding ferritin footprints in 5-fluorouracil-induced cardiotoxicity. 在5-氟尿嘧啶诱导的心脏毒性中发现铁蛋白足迹。

IF 3.2

Cardio-oncology Pub Date : 2026-04-10 DOI: 10.1186/s40959-026-00452-8

Grace M Ferri, Manuel Urina-Jassir, Alexander V Stanisic, Jack M Hensien, Grace Lee, Neal Sullivan, Omar K Siddiqi

{"title":"Finding ferritin footprints in 5-fluorouracil-induced cardiotoxicity.","authors":"Grace M Ferri, Manuel Urina-Jassir, Alexander V Stanisic, Jack M Hensien, Grace Lee, Neal Sullivan, Omar K Siddiqi","doi":"10.1186/s40959-026-00452-8","DOIUrl":"10.1186/s40959-026-00452-8","url":null,"abstract":"<p><p>Fluoropyrimidines, including 5-fluorouracil (5-FU), used in the treatment of patients with gastrointestinal malignancies, are associated with cardiotoxicity. Although the mechanism of this cardiotoxicity remains unknown, rat models treated with 5-FU have higher iron concentrations in myocardial tissue compared to controls. As a result, we sought to examine whether ferritin could be a clinical biomarker of cardiotoxicity among patients receiving 5-FU-based chemotherapy. We conducted a retrospective chart review on adult patients receiving 5-FU-based intravenous chemotherapy at a single academic center from June 2022 to 2024. Potential cardiotoxicity was defined by obstructive coronary artery disease, new wall motion abnormalities on transthoracic echocardiography (TTE), left ventricular ejection fraction decrease ≥10% from pre-treatment TTE, coronary vasospasm, pericardial effusion, or incident heart failure. Of our 93 patients, those with ferritin ≥ 100 ng/mL were nearly 5 times as likely to exhibit potential cardiotoxicity (adjusted odds ratio [aOR] 4.7, confidence interval [CI] 1.0-23.5) (Fig. 1A). Similarly, patients with ferritin ≥ 100 ng/mL were approximately 3 times as likely to experience treatment failure (aOR 3.2, CI 1.1-9.7). Based on the apparent relationship between ferritin ≥100 ng/mL, cardiotoxicity, and treatment outcomes, we encourage oncologists to routinely obtain iron studies in addition to pre- and post-treatment TTE among patients receiving 5-FU.</p>","PeriodicalId":9804,"journal":{"name":"Cardio-oncology","volume":"12 1","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13067715/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147653853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Outcomes associated with left atrial appendage occlusion in patients with cancer-associated atrial fibrillation: a real-world propensity-matched analysis. 癌症相关性心房颤动患者左心房附件闭塞的相关结果：一项真实世界倾向匹配分析

IF 3.2

Cardio-oncology Pub Date : 2026-04-09 DOI: 10.1186/s40959-026-00478-y

Rochell Issa, Tess Calcagno, Ryan Issa, Rohan Prasad, Patrick Collier, Arianne Agdamag, David C Kaelber, Diego Sadler, Alok A Khorana, Mohamed Kanj, Rohit Moudgil

引用次数: 0

Temporal trends, cardiovascular complications, and outcomes in patients receiving CAR T-cell therapy: a 6-year nationwide analysis. 接受CAR - t细胞治疗的患者的时间趋势、心血管并发症和结果：一项6年的全国分析

IF 3.2

Cardio-oncology Pub Date : 2026-04-07 DOI: 10.1186/s40959-026-00471-5

Karnav Modi, Himil Mahadevia, Raj Shah, Deepthi Vodnala, Talal Asif, Taiyeb Khumri, Furha Cossor

引用次数: 0

Improvement of cardiac function by Ivabradine in a doxorubicin-induced cardiomyopathy murine model is associated with a normal renal angiotensin II type I receptor expression but not with a reduction in fibrosis. 在阿霉素诱导的心肌病小鼠模型中，伊伐布雷定对心功能的改善与肾血管紧张素II I型受体的正常表达有关，但与纤维化的减少无关。

IF 3.2

Cardio-oncology Pub Date : 2026-04-06 DOI: 10.1186/s40959-026-00469-z

Gergana O Drumeva, Anne-Flore Plane, Daniil R Petrenyov, Paula A B Ribeiro, Cen Chen, Jean N DaSilva, François B Tournoux

引用次数: 0

Intrapericardial corticosteroid therapy for recurrent malignant pericardial effusion: a case series. 心包内皮质类固醇治疗复发性恶性心包积液：一个病例系列。